Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufangshuanghua (also known as Fufang Shuanghua Granule) is a Traditional Chinese Medicine (TCM) compound herbal preparation formulated as a granule for oral administration. It is primarily indicated for the treatment of acute upper respiratory tract infections, particularly those diagnosed as wind-heat syndrome according to TCM principles. The preparation is designed to clear heat and detoxify, a therapeutic strategy in TCM for managing febrile and inflammatory conditions. In clinical research, Fufangshuanghua has been utilized as an active comparator in Phase 4 randomized controlled trials to evaluate the efficacy and safety of other TCM treatments, such as Jinyebaidu Granule. Its composition typically centers on botanical ingredients like honeysuckle flower (Lonicera japonica), though it is a multi-component mixture rather than a single molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fufangshuanghua.